Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.
Januschowski K, Dimopoulos S, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G; Bevacizumab Study Group Venous Occlusion; Meyer CH, Szurman GB. Januschowski K, et al. Among authors: szurman gb, szurman p. Acta Ophthalmol. 2015 Aug;93(5):e400-e402. doi: 10.1111/aos.12600. Epub 2015 Jan 25. Acta Ophthalmol. 2015. PMID: 25619682 Free article. No abstract available.
Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.
Spitzer MS, Yoeruek E, Sierra A, Wallenfels-Thilo B, Schraermeyer U, Spitzer B, Bartz-Schmidt KU, Szurman P. Spitzer MS, et al. Among authors: szurman p. Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1837-42. doi: 10.1007/s00417-007-0568-7. Epub 2007 Mar 9. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17347807
Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
Yoeruek E, Ziemssen F, Henke-Fahle S, Tatar O, Tura A, Grisanti S, Bartz-Schmidt KU, Szurman P; Tübingen Bevacizumab Study Group. Yoeruek E, et al. Among authors: szurman p. Acta Ophthalmol. 2008 May;86(3):322-8. doi: 10.1111/j.1600-0420.2007.01049.x. Epub 2007 Nov 8. Acta Ophthalmol. 2008. PMID: 17995975 Free article.
Bevacizumab as adjuvant for neovascular glaucoma.
Beutel J, Peters S, Lüke M, Aisenbrey S, Szurman P, Spitzer MS, Yoeruek E; Bevacizumab Study Group; Grisanti S. Beutel J, et al. Among authors: szurman p. Acta Ophthalmol. 2010 Feb;88(1):103-9. doi: 10.1111/j.1755-3768.2008.01355.x. Epub 2009 Sep 20. Acta Ophthalmol. 2010. PMID: 18811641 Free article.
318 results